Ignacio Martinez

General Partner at Flagship Pioneering · Boston, United States

Invests in AI

Ignacio Martinez's investor profile lists AI alongside Biotech & Pharma, Food & Beverage and AgTech & Agriculture, at early-stage venture. The record holds 66 deals, among them KSQ Therapeutics, Invaio and Denali Therapeutics.

Email Investor

Email Investor

Credits to line up before an early-stage round

Ignacio Martinez backs companies at early-stage venture. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • KSQ Therapeutics
  • Invaio
  • Denali Therapeutics
  • Syros Pharmaceuticals
  • Incredible Foods
  • Montai Health
  • Inzen Therapeutics
  • Biognosys AG
  • Ohana Biosciences
  • T2 Biosystems
  • Tangent Medical Technologies
  • Kaleido BioSciences
  • Population Genetics Technologies
  • Permeon Biologics
  • Kovio
  • Oasys Water
  • Editas Medicine
  • Tessera Therapeutics
  • Ring Therapeutics
  • Moderna Therapeutics
  • Omega Therapeutics
  • Cygnal Therapeutics
  • Sana Biotechnology
  • Seres Therapeutics
  • Agios Pharmaceuticals
  • Novomer, Inc.
  • Red Rock Biofuels
  • Tarveda Therapeutics
  • Receptos
  • Repertoire Immune Medicines
  • Generate Biomedicines
  • EuroFerm GmbH
  • Codiak Biosciences
  • BlackDuck
  • Polatis
  • Chamelic Ltd
  • Seventh Sense Biosystems
  • Syngenta Ventures
  • Sigilon Therapeutics
  • Boragen
  • TARIS Biomedical
  • TransMedics
  • Selecta Biosciences
  • Quanterix
  • Visterra
  • Sesen Bio, Inc.
  • CiBO Technologies
  • medidametrics
  • Rubius Therapeutics
  • Axcella

Showing 50 of 66 deals on record.

Investment focus

Backs startups in
Artificial Intelligence, Biotech & Pharma, Food & Beverage, AgTech & Agriculture
Rounds
Early-stage venture
Profile
Venture investor
Deals on record
66
Based in
Boston, United States

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Ignacio Martinez invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Ignacio Martinez's investor profile, together with Biotech & Pharma, Food & Beverage and AgTech & Agriculture. The stages on record are early-stage venture.
Which companies has Ignacio Martinez backed?
The record lists 66 deals, including KSQ Therapeutics, Invaio, Denali Therapeutics, Syros Pharmaceuticals and Incredible Foods. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Ignacio Martinez?
For a company raising an early-stage round, AI Perks lists credits such as Microsoft Azure (up to $25,000), IBM Cloud (up to $120,000), Deepgram (up to $100,000) and Beefree SDK (up to $10,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor